Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw
Launched by ORTHOPEDIC HOSPITAL VIENNA SPEISING · Dec 1, 2022
Trial Information
Current as of January 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of screws used in surgery for flat feet, a condition where the arch of the foot falls. One screw is made from human bone, which could potentially make recovery easier since it doesn’t need to be removed later, while the other is a metal screw. The study aims to find out if the human bone screw works just as well as the metal screw in helping patients heal after surgery. Researchers will compare how well each screw helps the foot heal, the time it takes for the bones to fuse together, any complications that arise, and how patients feel about their foot function after the surgery.
To participate in this study, you must be an adult with specific foot issues and a body mass index (BMI) of less than 40. The trial is open to all genders and involves having surgery, followed by several check-ups over the next two years to assess your recovery. During these visits, you’ll have X-rays and CT scans to monitor the healing process, and you’ll also answer questions about your activity levels. This trial is important for understanding the best options for treating flat feet, so if you think you might be eligible, it could be a great opportunity to contribute to this research.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Indication for the use of a metal/Bio-Tenodesis screw or human bone screw in medializing calcaneus osteotomy with FDL transfer.
- • BMI\< 40 kg/m²
- Exclusion Criteria:
- • Insufficient knowledge of German
- • Alcohol and drug abuse
- • Pregnant woman or nursing mother
- • Foreseeable compliance problems
- • Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
- • Active osteomyelitis
- • History of foot surgery
- • Advanced osteoarthritis of the lower ankle joint
- • Ulcerations in the skin of the surgical area
- • Immunosuppressive medications that cannot be discontinued
- • BMI \>40
Trial Officials
Florian Wenzel-Schwarz, MD
Principal Investigator
Abteilung für Kinderorthopädie und Fußchirurgie Orthopädisches Spital Speising, Vienna, Austria
About Orthopedic Hospital Vienna Speising
The Orthopedic Hospital Vienna Speising is a leading specialized medical institution dedicated to the diagnosis, treatment, and rehabilitation of musculoskeletal disorders. Renowned for its commitment to excellence in orthopedic care, the hospital integrates cutting-edge research with clinical practice, facilitating innovative clinical trials aimed at advancing treatment options and improving patient outcomes. With a multidisciplinary team of experienced healthcare professionals, the Orthopedic Hospital Vienna Speising is at the forefront of orthopedic research, striving to enhance the quality of life for patients through evidence-based practices and state-of-the-art technology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials